Latest News

Stryker’s Physio-Control wins FDA PMA for Lifepak defibs

Physio-Control

Stryker‘s (NYSE:SYK) Physio-Control business said today it won FDA premarket approval for the continued marketing and distribution of its Lifepak professional defibrillators in the US.

The clearance includes its Lifepak 1000, refurbished Lifepak 20 defibrillator and monitor, Lifepak 20e defibrillator and monitor and the Lifepak 15 defibrillator and monitor, the Redmond, Wash.-based company said.

“Physio-Control is excited to have reached this major milestone with our complete portfolio of devices in both the professional and public safety markets. This is the culmination of several years of significant work, substantiating the safety and effectiveness of our devices, and is the highest bar FDA Class III medical devices must meet. This represents our continued commitment to producing the most reliable, highest quality, and science-driven products that our customers need to support their patients and communities,” Stryker EMS & Physio-Control VP and GM Anne Mullally said in a press release.

In February, Physio-Control initiated a select recall of its Lifepak 20e defibrillators and monitors over issues with power failures, according to a recall notice posted this month.

The post Stryker’s Physio-Control wins FDA PMA for Lifepak defibs appeared first on MassDevice.

Related posts

Medical News Today: What to know about guanfacine for the treatment of ADHD

Newsemia

Opinion: Precision medicine: course correction urgently needed

Newsemia

Tobacco products more aggressively marketed in Milwaukee's minority neighborhoods

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World